home / stock / snse / snse articles

SNSE Articles, Sensei Biotherapeutics Inc.

Stock Information
Company Name: Sensei Biotherapeutics Inc.
Stock Symbol: SNSE
Market: NASDAQ
Menu
SNSE SNSE Quote SNSE Short SNSE News SNSE Articles SNSE Message Board
Get SNSE Alerts

News, Short Squeeze, Breakout and More Instantly...
Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference | Benzinga

BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the dis...
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of NetEase, Inc. (NASDAQ:NTES) fell during Friday's session after the company reported worse-than-expected first-quarter revenue. NetEa...

Dow Surges 50 Points; US Durable Goods Orders Increase In April | Benzinga

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 50 points on Friday. Following the market opening Friday, the Dow t...

Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Ross Stores, Inc. (NASDAQ:ROST) rose sharply in today's pre-market trading after the company reported better-than-expected earnings ...
Sensei Biotherapeutics to Participate in Canaccord Genuity's Horizons in Oncology Virtual Conference | Benzinga

BOSTON, April 09, 2024 (GLOBE NEWSWIRE) --  Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), an immuno-oncology company focused on the discovery and...

Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium | Benzinga

BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the d...

Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences | Benzinga

BOSTON, March 06, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the d...
Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights | Benzinga

- SNS-101 initial Phase 1 clinical data presented at SITC demonstrate potential best-in-class safety and pharmacokinetic profile, with no cytokine...

Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket | Benzinga

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The com...

Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer | Benzinga

BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the di...
Next 10